Allergic rhinitis might be caused by decreased resistance of nasal barrier to allergens and
other environmental insults. About 20 % of the European population suffers from pollen
allergies. Birch pollen allergic rhinitis is the most common allergic disease in the
Scandinavia and it exists widely also in the Central Europe. Suffering and high costs of
pollen allergies may be reduced by understanding the molecular biology of the nasal barriers
during allergic response. Our aim is to observe the effect of season and birch pollen
immunotherapy on the molecular biology of nasal epithelium and the microbiome.
Phase:
N/A
Details
Lead Sponsor:
Helsinki University Central Hospital
Collaborators:
Finnish Institute of Occupational Health Helsinki University University of Helsinki